Your browser doesn't support javascript.
loading
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
Feliu, Jaime; Jorge Fernández, Mónica; Macarulla, Teresa; Massuti, Bartomeu; Albero, Ana; González González, José Federico; Quintero-Aldana, Guillermo; Delgado-Mingorance, Juan Ignacio; Fernández Montes, Ana; García Piernavieja, Carmen; Valladares-Ayerbes, Manuel; López Muñoz, Ana María; Mondéjar Solís, Rebeca; Vicente, Pilar; Casado Gonzalez, Esther; González Cebrián, Irene; López-Vivanco, Guillermo.
Afiliación
  • Feliu J; Medical Oncology Department, IdiPAZ, CIBERONC, Cátedra UAM-AMGEN, Hospital Universitario La Paz, Paseo de la Castellana 261., 28046, Madrid, Spain. jaimefeliu@hotmail.com.
  • Jorge Fernández M; Medical Oncology Department, Hospital Álvaro Cunqueiro, Vigo, Spain.
  • Macarulla T; Medical Oncology Department, Vall d'Hebrón University Hospital and Vall d'Hebrón Institute of Oncology, IOB Quirón, Barcelona, Spain.
  • Massuti B; Medical Oncology Department, Alicante University Hospital ISABIAL, Alicante, Spain.
  • Albero A; Medical Oncology Department, Hospital Virgen Macarena, Sevilla, Spain.
  • González González JF; Medical Oncology Department, Hospital Universitario Quirónsalud Madrid, Madrid, Spain.
  • Quintero-Aldana G; Medical Oncology Department, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain.
  • Delgado-Mingorance JI; Medical Oncology Department, Hospital Universitario Badajoz, Badajoz, Spain.
  • Fernández Montes A; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain.
  • García Piernavieja C; Medical Oncology Department, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Valladares-Ayerbes M; Medical Oncology Department, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • López Muñoz AM; Medical Oncology Department, Hospital Universitario de Burgos, Burgos, Spain.
  • Mondéjar Solís R; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain.
  • Vicente P; Medical Oncology Department, Hospital Granollers, Granollers, Spain.
  • Casado Gonzalez E; Medical Oncology Department, Hospital Althaia, Manresa, Spain.
  • González Cebrián I; Digestive Cancer Department, San Cecilio Hospital, Granada, Spain.
  • López-Vivanco G; Medical Oncology Department, Hospital Universitario Cruces, Barakaldo, Spain.
Cancer Chemother Pharmacol ; 87(4): 543-553, 2021 04.
Article en En | MEDLINE | ID: mdl-33452559
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Albúminas Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Chemother Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Albúminas Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Chemother Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: España